The Hope Project (THP): Understanding Multiple Sclerosis

Updated: Dec 8, 2021

Multiple Sclerosis is, in part, an autoimmune neurological disorder. It is considered rare, and it requires control and treatment. Moreover, it is a disease that tells your body to “eat away” the myelin that surrounds the nerve fibers. This leads to communication problems between the brain and the rest of the body. The patient’s symptoms vary depending on the nerve damage.

This article provides insight into the etiology (causes), the physiological effects, the neuropathology, and management of Multiple Sclerosis.

What is Multiple Sclerosis?

Multiple Sclerosis is an inflammatory demyelinating disease that affects the brain and spinal cord, which leads to potential mobility issues. Tremors, limb numbness, slurred speech, and fatigue are common symptoms of MS. This disease is characterized by damage to the myelin surrounding nerve fibers, causing symptoms to vary depending on the area that has the damage. Moreover, it is considered, in part, an autoimmune disease, because your body is told to eat away myelin. There is a lot of controversy on whether this is an autoimmune disease, or not.

Why is there controversy on whether it is an autoimmune disease or not?

Multiple Sclerosis isn’t directly caused by the immune system. The cause of MS is unknown, however, it is believed to be a combination of environmental and genetic factors, such as age, sex, certain infections, race, climate, etc. Autoimmune diseases are characterized by the body attacking itself due to loss of control against healthy cells.

MS is a disease where the body destroys myelin that surrounds the nerve fibers. Studies consider MS a neuroinflammatory demyelinating autoimmune disease.

However, patients should not get overwhelmed by these strange words, instead of going to a doctor and treating MS is the best way to avoid pain and physiological malfunction.

How do doctors study the severity of MS?

Depending on the area affected, the symptoms and course of the disease vary from person to person. The severity is mainly classified based on how much damage the disease has done to the mobility of the patient. A patient that hasn’t lost a lot of movement, would be considered someone who doesn’t have a severe case of MS. However, patients that cannot move their limbs anymore, would be considered severe cases. A study by Dr. Herbert, who studied 50 different individuals, showed that the majority of MS patients have a severity that is considered intermediate. Whether a person has one or five symptoms, they should still go to the doctor to ensure that they are healthy or receiving the correct treatments.

What are treatments (nootropics and technology) for Multiple Sclerosis?

The development of methods to treat Multiple Sclerosis has been a priority for many scientists and researchers. For patients who have active recurring MS, which means that a person has two or more relapses in the last 2 years, the most common medication is interferon beta. These reduce serious relapses, fewer brain and spinal cord lesions, and reductions in the severity of the disease. This medication, as well as others, has to be guided by doctors and professionals. Maintaining a healthy lifestyle and attending physical therapy may help the MS patient, however, certain technologies and non-invasive medications can be prescribed by the doctor managing MS, whether it is a Rheumatologist or a Neurologist.

Where can you learn more about MS?

There are many Multiple Sclerosis organizations that teach about this disorder, including:

These websites support the continuation of research for Multiple Sclerosis, they provide resources for patients, caregivers, and people interested in MS.


Multiple Sclerosis is an autoimmune demyelinating neuroinflammatory disease that affects around 200, 000 people each year in the United States. It is a disease that affects the myelin that surrounds the nerve fibers. It leads to symptoms that generally affect the sensory system, vision, and motor system, limb movement, and numbness. Overall, MS is a disease that needs to be diagnosed and treated. Keeping a healthy lifestyle and maintaining a positive mindset are key for MS patients.


Unwired India is a neurotech-startup that aims at integrating state-of-the-art research and developments in STEM, for catalyzing the transition of Neuroscience to Neurotechnology. We develop avant-garde non-invasive neurostimulation products used to solve some of the world’s most critical global issues and challenges. Our mission is to take cutting-edge brain research directly into the lives and homes of people, thereby fostering a unique culture of sustainable neuroscience and scientific literacy in India.

  • Founded in 2020, we are the pioneers of Nootropics and non-invasive Neurotechnology devices in the country, and offer so much more than high-quality, delicious Brain Nutrition products for daily cognitive support; a full-service health and fitness startup that has become an important part of the local community, here in New Delhi, India.

  • We develop non-GMO, all-natural nootropic (smart-drug) formulations, Himalayan herb blends, and specialized amino-nutraceutical interventions and supplements for enhanced brain function, cognition, neuroinflammation, and neurodegeneration.


The Hope Project (THP) is a neuro-disorder awareness initiative within the organizational framework of Unwired India. The initiative aims at creating and scaling awareness against the stigma, fear, and apprehensions associated with Neurological disorders.

Aims: To promote and develop awareness across global masses and to emphasize the importance of early detection, in addition to fostering a healthy lifestyle- which is important in the management and treatment of these ailments.


Register at


A friendly reminder: We've done our research, but you should too! Check our sources against your own and always exercise sound judgment. 50269 

Image Credits: 


About the Author

Raquel Paz Bergia

Leader of The Hope Project & International Growth Ambassador (Madrid, Spain)

Raquel Paz Bergia is a writer from Spain who developed an interest in Neurology at an early age. Over the last few years, she has surrounded her studies around Cognitive Biomedical Engineering. She has a passion for learning and researching degenerative diseases and their impact on the community.

2,441 views0 comments